Fundraising FoxDelaware Crossing Investor Group — Full Portfolio
71 tracked investments · listed companies and verified rows first
Immunome is a clinical-stage oncology company developing targeted cancer therapies, including antibody-drug conjugates (ADCs) and small molecules, to address unmet medical needs in cancers such as lymphoma and bladder cancer.
BiotechHealthtechExton, US
Scott K. Dessain(Executive Officer, Director)inDennis H Giesing(Executive Officer)inCorleen Roche(Executive Officer)inMichael J Morin(Executive Officer)Purnanand Sarma(Executive Officer, Director)inGeorge Hobbs(Executive Officer)
Co-investorsBioAdvanceEvolution VC PartnersMilitia Hill VenturesPivotal Life SciencesRobin Hood VenturesT. Rowe Price
AcademyOne builds SaaS tools and automated workflows that help colleges, universities, and governance organizations manage enrollment, academic credit portability, and degree completion.
EdTechSaaS
CytoAgents is a clinical-stage biopharmaceutical company developing therapies for the life-threatening symptoms of Cytokine Release Syndrome (CRS), an immune overreaction causing systemic inflammation.
BiotechHealthtechPittsburgh, US
Teresa Whalen, RPh(Chief Executive Officer)inCatherine Mott(Director)Teresa Whalen(Chief Executive Officer)Anthony McCarley(Director)John Friedman(Director)Stanley Marks(Director)
Co-investorsBoston Harbor AngelsRichard King Mellon Foundation
GILSON Snow designs and handcrafts snowboards and skis in the USA using locally sourced Pennsylvania Poplar, building custom gear on demand for individual riders.
Advanced ManufacturingConsumerDirect to ConsumerSports TechSelinsgrove, US
Austin Royer(Co-founder)Nicholas Gilson(Founder)Andrew Mikowski(Executive Officer, Director)Adam Vanderhyden(Executive Officer, Director)Samantha Ginsberg(Director)David Johnson(Director)
Co-investorsWhite Rose VenturesKeystone Innovation
Grassroots Unwired provides mobile-first canvassing and field-organizing technology for political campaigns and nonprofit organizations, supporting voter outreach, fundraising, and constituent data capture.
FintechGovTechImpact & Social GoodSaaSYardley, US
RUSS OSTER(CEO)in
Co-investorsBen Franklin Technology PartnersBullpen CapitalRobin Hood Ventures
Holganix makes Bio 800+ soil products containing over 800 species of beneficial microorganisms that improve soil health, allowing farmers and turf professionals to reduce fertilizer and water use while increasing crop yields and carbon capture.
AgTechCleantechClimate TechImpact & Social GoodGlen Mills, US
Barrett Ersek(Founder & CEO)inGene Godick(Executive Officer)Bryan Hansel(Head of Revenue Strategy)inDavid Stark(Executive)inKaitlyn Ersek(Chief of Staff)inRadhika Moolgavkar(Vice President HGX, Product)in
Co-investorsAg Ventures AllianceArgonautic VenturesiSelect FundJumpStart New Jersey Angel NetworkCultivation Capital
Honeycomb Credit runs an investment crowdfunding platform where individuals can invest in local small businesses, such as breweries, restaurants, and shops, in exchange for potential returns.
FintechImpact & Social GoodMarketplacesPittsburgh, US
George Cook(Co-founder & CEO)inKen Martin(Founder)inMathias Jamora(CFO)inChristian Bilger(Executive Officer)Edward Engler(Director)
Co-investorsAmerican Family Insurance Institute for Corporate and Social ImpactCitta CapitalMudita VentureSustainVCSymphonic Capital3 Points Rising Ventures+2 more
KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply.
BiotechDeep TechHealthtechMedical DevicesBaltimore, US
Allan Doctor(Co-Founder & CSO)inDipanjan Pan(Co-Founder, Chief Technical Officer)inPhilip Spinella(Co-Founder, Chief Medical Officer)inDaniel Getman(Director)Gregory Lanza(Director)
Co-investorsBioAdvanceBioGenerator VenturesMaryland TEDCONYBC VenturesOld Line Capital PartnersTEDCO+1 more
LUXTECH manufactures LED modules for luminaire producers, enabling them to create globe illumination with single modular components.
Advanced ManufacturingCleantechHardwarePhiladelphia, US
Co-investorsBroad Street AngelsRobin Hood Ventures
Measure is a social media analytics platform for brand teams managing accounts across markets, agencies, and product lines.
AdTechAI & Machine LearningMarketing TechMedia & EntertainmentSaaSChalfont, US
Thomas Kramer(Executive Officer, Director)
BoardJames Creech(Director)inDan Zitting(Director)
Co-investors37 AngelsKern Venture GroupRobin Hood Ventures
Medcura develops hemostatic products made from hydrophobically modified biopolymers to control minimal, mild, and moderate surgical bleeding through mechanical mucoadhesion.
BiotechHealthtechMedical DevicesRiverdale, US
Jim Buck(President, CEO & Director)inMatthew Dowling, Ph.D(Dr. Dowling is the Chief Scientic Officer of the Issuer.)Rich Vincent(Mr. Vincent is the Chief Financial Officer of the Issuer.)Larry Tiffany(Mr. Tiffany is the Executive Chairman of the Issuer.)inPeter Thomas(Executive Officer, Director)Matthew Dowling(Executive Officer, Director)
Co-investorsAspira CapitalMaryland TEDCORobin Hood VenturesTEDCO
Dealum provides software tools for business angel networks and investor groups to manage operations, collaborate, and streamline deal-making processes.
Enterprise SoftwareFintechSaaS
Rain Kivisik(Founder)
Co-investorsAggie Angel NetworkAngel ForumBusiness Angels Club Berlin-Brandenburg e.V.Central Texas Angel NetworkDakar Network Angels (DNA)DanBAN+14 more
Nicklpass provides a platform for organizations to centralize the management, governance, and purchasing of digital tools and SaaS subscriptions across their teams.
Cloud ComputingCrypto & Web3Developer ToolsEnterprise SoftwareSaaSBrooklyn, US
Co-investorsDigital Currency GroupGreen Egg VenturesHustle FundReign VenturesRiverPark VenturesSixty8 Capital+2 more
Ophidion is an early-stage CNS biopharmaceutical company developing a non-invasive carrier technology that delivers gene-silencing agents and other therapeutics across the blood-brain barrier into the brain.
BiotechDeep TechHealthtechBethlehem, US
Julie Miwa(Director, Promoter)inYacoub Habib(Executive Officer, Director, Promoter)
BoardMichael Lark(Director)Scott Fishman(Director)Claudine Bruck(Director)
Co-investorsEisai Innovation, Inc.Robin Hood Ventures
BiotechKennett Square, US
Frank Minella(Executive Officer, Director)inAlexander Ruckdaeschel(Executive Officer, Director)
BoardJohn H. Stewart(Director)Andrew Koopman(Director)
Co-investorsItalian Angels for GrowthNYU Innovation Venture Fund
HealthtechAmbler, US
Tessie McNeely(Executive Officer, Director)inAdam Dakin(Executive Officer, Director)inMark Evan Schafer(Executive Officer, Director)
BoardMichael Wells(Director)
Doylestown, US
Jose Plehn-Dujowich(Executive Officer, Director)Kevin Sheetz(Executive Officer, Director)GEORGE A. MOSSMAN(Director)KENNETH DALY(Director)JANICE BURG-LEVI(Director)ROBERT KEITH(Director)
Co-investorsTribeca Early Stage PartnersBrewer Lane Ventures
Reflexion builds hardware devices and web-based software for cognitive training and tracking, using large touch-screen displays that measure and train functions like reaction time, decision-making, and short-term memory.
AI & Machine LearningHardwareHealthtechSports Tech
Co-investors1855 Capital PartnersInspovation VenturesSonder CapitalWhite Rose Ventures
Saladax Biomedical develops blood-level tests that help psychiatrists and oncologists determine correct individual drug dosages based on patient metabolism, supporting treatment decisions and reducing toxicity risk.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsExcel Venture ManagementLife Sciences Greenhouse InvestmentsGolden Seeds
Sauvie is developing a protein discovery platform in the biological intelligence space.
AI & Machine LearningBiotechDeep Tech
Co-investorsRobin Hood Ventures
Seamless is a revenue operations platform that uses AI to automate sales outreach and contact verification for sales, marketing, and customer success teams.
AI & Machine LearningSaaSSales TechWorthington, US
Brandon Bornancin(Founder)inDanielle Demming(Founder)in
Co-investors9Mile LabsBreak Trail VenturesNewark Venture Partners
Seneca Therapeutics develops oncolytic virus immunotherapies, particularly Seneca Valley Virus (SVV-001), for treating aggressive and therapy-resistant solid cancers.
BiotechDeep TechHealthtechMedical DevicesBlue Bell, US
Paul L. Hallenbeck(Founder, President and Chief Scientific Officer)inCuong Do(Executive Officer, Director)inJames Hussey(Executive Officer, Director)in
BoardMark Kerschner(Director)
Co-investorsBroad Street AngelsDellin InvestmentsKeiretsu ForumNW Angel
Sporttrade is a sports betting platform that modernizes the industry using proprietary technology and capital markets expertise, operating with a focus on equity, responsibility, and accessibility.
B2B MarketplacesFintechSports TechUnionville, US
Alexander Kane(Executive Officer, Director)inAnthony(Chief Financial Officer)Arpita(Chief Compliance Officer)Thomas Wittman(Director)David Frohardt-Lane(Director)
Co-investorsAcies InvestmentsBelvedere Strategic CapitalCTC VenturesLitquidity VenturesTechstarsImpression Ventures+2 more
SunRay Scientific develops anisotropic conductive adhesives (ZTACH ACE), conductive inks, epoxies, and related materials for printed and flexible electronics, integrable with existing pick-and-place manufacturing equipment.
Advanced ManufacturingHardwareNew MaterialsWall Township, US
Andrew Stemmermann(CTO, Co-Founder)inMadhu Stemmermann(CEO, Co-Founder)in
BoardSteve Socolof(Director)in
Co-investorsBroad Street AngelsCentral Texas Angel NetworkJumpStart New Jersey Angel NetworkSoundboard Venture FundWestchester AngelsGolden Seeds+1 more
Thrombolex develops endovascular catheters using pharmaco-mechanical technology to treat arterial and venous thromboembolic (A+VTE) conditions by dissolving blood clots.
BiotechHealthtechMedical DevicesKingston, US
Riyaz Bashir(Innovator / Creator of BASHIR Endovascular Catheters)John Cerminaro(Executive Officer)inMichael J. Cerminaro(Executive Officer, Director)inMarvin Woodall(Executive Officer, Director)Brian G. Firth(Executive Officer, Director)Todd Richmond(Director)
Co-investorsOrbiMed
Thubrikar Aortic Valve is a medical device company developing a transcatheter aortic valve (the Optimum TAV) focused on valve durability, aimed at clinicians treating aortic valve disease.
HealthtechMedical DevicesBoston, US
Mano Thubrikarin
TicketLeap is an online event ticketing platform that lets organizers create accounts and sell event tickets, with mobile-optimized event management tools.
MarketplacesMedia & EntertainmentSaaSPhiladelphia, US
Stanchak Christopher(Executive Officer, Director)Tim Raybould(Executive Officer)in
BoardPeter Albert(Director)James Thompson(Director)Michael Aronson(Director)inColin Evans(Director)in
Co-investorsBeacon AngelsRobin Hood VenturesBen Franklin Technology Partners
Trace Orthopedics is developing a device and technique (the Trace Method) to repair partially torn tendons back to bone through a needle inserted through the skin, avoiding open or arthroscopic surgery and general anesthesia.
HealthtechMedical DevicesPhiladelphia, US
William B. Morrison(Co-Founder & Medical Director)Adam Greenspan(President & CEO)
Co-investorsCentral Texas Angel Network
Vytala is a foodtech company that develops nutrition solutions to address fat malabsorption and other nutrient deficiencies.
BiotechDigital HealthFoodTechHealthtechMedical Devices
Jim O'Connell(CEO and Founder)in
Co-investorsRobin Hood VenturesThe MBA FundUlu Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AnglrAnnovis BioBambuBarkly PetsBiologics MDBridge SemiconductorCEPHEACompliance Assurance CorporationEdge TherapeuticsEvrys BioFinancial TrackingFuegoGenproHulafrogLiaLuxtexhMoreBankMyotaNanoPackNextStage CapitalNoviraOnlySky, Inc.Oral BiolifePervasive Group’s MMGuardianPledgeITPreclickReliefbandSequenomSmartStructuresSnowvationSocial LadderSonnest, IncSquareknotStabilizOrthoStarrStoopStradosThruPoreThruPore TechnologiesToblyUnirisxZive
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.